10-propargyl-10-deazaaminopterin has been researched along with Local Neoplasm Recurrence in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 7 (35.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altınay, S; Kural, A; Özmen, A; Tural, D; Tutar, Y | 1 |
| Kaur, H; Lee, YS; Ong, SY; Phipps, C; Tan, L | 1 |
| Karasuno, T; Sata, H; Sawada, K; Yasumi, M | 1 |
| Maeda, Y; Tobinai, K; Yeoh, EM; Zhu, J | 1 |
| Admojo, L; Bazargan, A; Bhurani, M; Coyle, L; Dickinson, M; Dunlop, L; Giri, P; Gutta, N; Hawkes, E; Hua, M; Irving, I; Kennedy, G; Khoo, L; Kipp, D; Lindsay, J; McCormack, C; McQuillan, A; Moreton, S; Panicker, S; Prince, HM; Quach, H; Radeski, D; Scott, A; Trotman, J; Twigger, R; Van Der Weyden, C; Yeung, J; Yuen, S; Zimet, A | 1 |
| Baik, D; Cho, H; Cho, S; Kang, HY; Kim, AY; Lee, H; Park, S | 1 |
| Fujioka, A; Kobashi, H; Kusume, E; Nakajima, H; Oguro, T; Sano, H; Sano, S; Teraishi, M; Yamamoto, M | 1 |
| Amengual, J; Colbourn, D; Deng, C; O'Connor, OA; Sawas, A | 1 |
| Beltran, BE; Conlon, K; Cook, L; Dwyer, K; Feldman, T; Fields, PA; Gonsky, J; Hermine, O; Horwitz, SM; Humphrey, J; Kurman, M; Leoni, M; Moriya, J; Pereira, J; Phillips, AA; Ramos, JC; Sawas, A; Taylor, GP; Wandroo, F | 1 |
| Ito, Y; Makita, S; Tobinai, K | 1 |
| Shinohara, MM; Shustov, A; Tarabadkar, ES; Ware, O | 1 |
| Apollo, A; Cox, L; Fury, MG; Haque, S; Ho, AL; Lipson, BL; Lyo, JK; Pfister, DG; Sales, R; Seetharamu, N; Sherman, EJ; Sima, CS; Xiao, H | 1 |
| Duvic, M; Gangar, P; Talpur, R; Thompson, A | 1 |
| Berube, C; Coutré, SE; Dinner, S; Dunn, TJ; Gotlib, J; Hao, Y; Liedtke, M; Medeiros, BC; Price, E | 1 |
| Ahn, JS; Cho, MS; Jung, SH; Jung, SY; Kim, HJ; Kim, YK; Lee, JJ; Lee, SS; Yang, DH | 1 |
| Atkinson, T; Birrer, MJ; Campos, SM; Clark, RM; Del Carmen, MG; Horick, NK; Krasner, CN; Rauh-Hain, JA; Supko, JG | 1 |
| Bartlett, N; Boyd, A; Coiffier, B; Crump, M; Furman, R; Gisselbrecht, C; Goy, A; Haioun, C; Horwitz, S; Hsi, E; Jacobsen, E; Lechowicz, MJ; O'Connor, OA; Pinter-Brown, L; Popplewell, L; Pro, B; Savage, KJ; Shustov, AR; Zain, JM; Zinzani, PL | 1 |
| Foss, F | 1 |
| Elefante, A; Hui, J; Przespo, E | 1 |
| Berthelot, CN; Duvic, M; Jones, D; Leitenberger, JJ; McLaughlin, P; Polder, KD; Pro, B | 1 |
4 review(s) available for 10-propargyl-10-deazaaminopterin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind.
Topics: COVID-19; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; SARS-CoV-2; Skin Neoplasms; Systematic Reviews as Topic; United States | 2023 |
Pralatrexate: a comprehensive update on pharmacology, clinical activity and strategies to optimize use.
Topics: Aminopterin; Clinical Trials as Topic; Drug Resistance, Neoplasm; Drug Therapy; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Treatment Outcome | 2017 |
Development of new agents for peripheral T-cell lymphoma.
Topics: Aminopterin; Aminopyridines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Brentuximab Vedotin; China; Depsipeptides; Drug Approval; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunoconjugates; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Sulfonamides | 2019 |
Pralatrexate: a novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses.
Topics: Aminopterin; Animals; Clinical Trials as Topic; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local | 2012 |
5 trial(s) available for 10-propargyl-10-deazaaminopterin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Mogamulizumab
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Humans; International Agencies; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Oxaliplatin; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Young Adult | 2019 |
A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer.
Topics: Adult; Aged; Aminopterin; Carcinoma, Squamous Cell; Disease Progression; Female; Folic Acid; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck; Vitamin B 12; Vitamin B Complex; Young Adult | 2014 |
A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma.
Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Treatment Outcome | 2016 |
Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Topics: Adult; Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Carcinosarcoma; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Survival Rate; Tissue Distribution | 2016 |
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Drug Resistance, Neoplasm; Female; Folic Acid Antagonists; Humans; International Agencies; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Salvage Therapy; Standard of Care; Survival Rate; Treatment Outcome; Young Adult | 2011 |
11 other study(ies) available for 10-propargyl-10-deazaaminopterin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Pralatrexate Induces Long-Term Remission in Relapsed Subcutaneous Panniculitis-Like T-Cell Lymphoma.
Topics: Adult; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Cyclophosphamide; Deoxycytidine; Dexamethasone; Doxorubicin; Folic Acid Antagonists; Gemcitabine; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell, Peripheral; Male; Neoplasm Recurrence, Local; Panniculitis; Prednisone; Remission Induction; Subcutaneous Fat, Abdominal; Vincristine | 2019 |
[Leucovorin Administration Allows Continued Pralatrexate Treatment in a Patient with Angioimmunoblastic T-Cell Lymphoma].
Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Folic Acid Antagonists; Humans; Leucovorin; Lymphoma, T-Cell; Male; Neoplasm Recurrence, Local | 2020 |
Efficacy and safety of single-agent pralatrexate for treatment of angioimmunoblastic T-cell lymphoma after failure of first line therapy: a pooled analysis.
Topics: Aminopterin; China; Humans; Japan; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies | 2020 |
Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.
Topics: Aged; Aminopterin; Australia; Humans; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2021 |
Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial.
Topics: Aminopterin; Case-Control Studies; Cost-Benefit Analysis; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Neoplasm Recurrence, Local | 2020 |
Pralatrexate for refractory mycosis fungoides in two Japanese patients.
Topics: Aminopterin; Humans; Japan; Mycosis Fungoides; Neoplasm Recurrence, Local; Skin Neoplasms | 2021 |
Pralatrexate for refractory or recurrent subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome.
Topics: Aged; Aminopterin; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Panniculitis; Retrospective Studies; Young Adult | 2020 |
Pralatrexate alone or in combination with bexarotene: long-term tolerability in relapsed/refractory mycosis fungoides.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; Retrospective Studies; Tetrahydronaphthalenes; Treatment Outcome | 2014 |
Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients.
Topics: Aged; Aminopterin; Antineoplastic Agents; Bortezomib; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lymphoma, T-Cell, Peripheral; Male; Neoplasm Recurrence, Local; Neutropenia; Positron Emission Tomography Computed Tomography | 2016 |
Hematology: relapsed and refractory PTCL--into the therapeutic abyss.
Topics: Aminopterin; Antineoplastic Agents; Drug Resistance, Neoplasm; Folic Acid Antagonists; Hematology; Humans; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Salvage Therapy | 2011 |
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Dendritic Cells; Doxorubicin; Drug Therapy, Combination; Female; Folic Acid; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Skin Neoplasms; Treatment Outcome; Vincristine; Vitamin B 12 | 2008 |